0 Ask Beta Account

Oestriol and prevention of breast cancer

HenryM. Lemon

  • University of Nebraska Medical Center ROR

Lancet (London, England), 1(7802), 546-547

DOI 10.1016/s0140-6736(73)90353-x PMID 4119971

Abstract

Findings of estriol protective action against chemical carcinogens used to induce breast cancer in laboratory animals.

Topics

Reproductive Endocrinology > Estrogens > Estriol and Cancer ProtectionGeneral OB/GYN > Breast Health > Hormonal Cancer Prevention
estriol breast cancer prevention protective action, Lemon HM estriol breast cancer 1973, estriol protective effect chemical carcinogen breast cancer animal model, estrogen type breast cancer risk estriol versus estradiol, estriol anticarcinogenic properties mammary gland, hormone protective factor breast cancer prevention, estriol estrogen metabolism breast cancer chemoprevention, laboratory animal breast cancer carcinogen estriol protection
PMID 4119971 4119971 DOI 10.1016/s0140-6736(73)90353-x 10.1016/s0140-6736(73)90353-x

Cite this article

Lemon, H. M. (1973). Oestriol and prevention of breast cancer. *Lancet (London, England)*, *1*(7802), 546-547. https://doi.org/10.1016/s0140-6736(73)90353-x

Keywords

Adolescent, Adult, Animals, Benz(a)Anthracenes, Breast Neoplasms/prevention & Control/urine, Estriol/physiology/therapeutic Use/urine, Female, Humans, Hydroxylation, Mammary Neoplasms, Experimental/chemically Induced/prevention & Control, Procarbazine, Rats, Benz(a)Anthracenes, Procarbazine, Estriol

Related articles

Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023
GBD 2023 Intimate Partner Violence and Sexual Violence against Children Collaborators, 2026 Lancet (London, England)

BACKGROUND: Violence against women and against children are human rights violations with lasting harms to survivors and societies at large. Intimate partner violence (IPV) and sexual violence against ...

General OB/GYNEthics/Philosophy

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023
GBD 2023 Disease and Injury and Risk Factor Collaborators, 2025 Lancet (London, England)

BACKGROUND: For more than three decades, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) has provided a framework to quantify health loss due to diseases, injuries, and associate...

Research MethodologyGeneral OB/GYN

Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies
International Collaboration of Epidemiological Studies of Cervical Cancer et al., 2007 Lancet (London, England)

Background: Combined oral contraceptives are classified by the International Agency for Research on Cancer as a cause of cervical cancer. As the incidence of cervical cancer increases with age, the pu...

Contraception/Comparison > Adverse Effects > Cervical Cancer RiskGeneral OB/GYN > Gynecologic Oncology > Cervical Cancer EpidemiologyResearch Methodology > Study Design > Pooled Individual Data Reanalysis